Screening, early detection, education, and trends for melanoma: Current status (2007-2013) and future directions Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology

Journal of the American Academy of Dermatology

Volumn 71, Issue 4, 2014, Pages 599.e1-599.e12

  Mayer, Jonathan E ^a,b   Swetter, Susan M ^c,d   Fu, Teresa ^c   Geller, Alan C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b College of Physicians and Surg ^*  (United States)

^c STANFORD UNIVERSITY   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 1 RECEPTOR;

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHILDHOOD CANCER; CONFOCAL LASER MICROSCOPY; DERMATOSCOPE; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; EPILUMINESCENCE MICROSCOPY; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MELANOMA; PARKINSON DISEASE; PHOTOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUN EXPOSURE; TOTAL BODY PHOTOGRAPHY;

EID: 84922660073     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.05.046     Document Type: Review

References (77)

1. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions. J Am Acad Dermatol 2007;57:555-72.
2. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)eassociated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013;105: 175-201.
3. Geller AC, Clapp RW, Sober AJ, Gonsalves L, Mueller L, Christiansen CL, et al. Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry. J Clin Oncol 2013;31:4172-8.
4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
5. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol 2009;129:1666-74.
6. Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2007. Bethesda (MD): National Cancer Institute; 2010.
7. Myles ZM, Buchanan N, King JB, Singh S, White A, Wu M, et al. Anatomic distribution of malignant melanoma on the non-Hispanic black patient, 1998-2007. Arch Dermatol 2012; 148:797-801.
8. Cockburn MG, Zadnick J, Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer 2006;106:1162-8.
9. Pollitt RA, Clarke CA, Swetter SM, Peng DH, Zadnick J, Cockburn M. The expanding melanoma burden in California hispanics: importance of socioeconomic distribution, histologic subtype, and anatomic location. Cancer 2011; 117:152-61.
10. Clark LN, Shin DB, Troxel AB, Khan S, Sober AJ, Ming ME. Association between the anatomic distribution of melanoma and sex. J Am Acad Dermatol 2007;56:768-73.
11. Caini S, Gandini S, Sera F, Raimondi S, Fargnoli MC, Boniol M, et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer 2009;45:3054-63.
12. Butler ST, Fosko SW. Increased prevalence of left-sided skin cancers. J Am Acad Dermatol 2010;63:1006-10.
13. Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One 2010;5:e9584.
14. Gamba CS, Clarke CA, Keegan TH, Tao L, Swetter SM. Melanoma survival disadvantage in young, non-Hispanic white males compared with females. JAMA Dermatol 2013; 149:912-20.
15. Fisher DE, Geller AC. Disproportionate burden of melanoma mortality in young U.S. men: the possible role of biology and behavior. JAMA Dermatol 2013;149:903-4.
16. Hussain SK, Lenner P, Sundquist J, Hemminki K. Influence of education level on cancer survival in Sweden. Ann Oncol 2008;19:156-62.
17. Pollitt RA, Swetter SM, Johnson TM, Patil P, Geller AC. Examining the pathways linking lower socioeconomic status and advanced melanoma. Cancer 2012;118:4004-13.
18. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009;27:3-9.
19. Buljan M, Rajácóc N, VurnekZivkovíc M, Blajíc I, Kusíc Z,Situm M. Epidemiological data on melanoma from the referral centre in Croatia (2002-2007). Coll Antropol 2008; 32(suppl 2):45-7.
20. Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol 2012;167: 1124-30.
21. Shaikh WR, Xiong M, Weinstock MA. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. Arch Dermatol 2012;148:30-6.
22. Warycha MA, Christos PJ, Mazumdar M, Darvishian F, Shapiro RL, Berman RS, et al. Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer 2008;113:3341-8.
23. Geller AC, Elwood M, Swetter SM, Brooks DR, Aitken J, Youl PH, et al. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer 2009;115: 1318-27.
24. Cust AE, Goumas C, Holland EA, Agha-Hamilton C, Aitken JF, Armstrong BK, et al. MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study. Int J Cancer 2012;131:E269-81.
25. Pappo AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, et al. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatr Blood Cancer 2013;60:461-6.
26. Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, et al. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2012;104:1240-50.
27. National Cancer Institute web site. Late effects of treatment for childhood cancer (PDQ). Available at: http://www. cancer.gov/cancertopics/pdq/treatment/lateeffects/Health Professional/page2. Accessed March 8, 2014.
28. Nathan PC, Ness KK, Mahoney MC, Li Z, Hudson MM, Ford JS, et al. Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Intern Med 2010;153:442-51.
29. Brewer JD, Christenson LJ, Weaver AL, Dapprich DC, Weenig RH, Lim KK, et al. Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol 2011; 147:790-6.
30. Hollenbeak CS, Todd MM, Billingsley EM, Harper G, Dyer AM, Lengerich EJ. Increased incidence of melanoma in renal transplantation recipients. Cancer 2005;104:1962-7.
31. Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011;20:2551-9.
32. Bajaj A, Driver JA, Schernhammer ES. Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 2010;21:697-707.
33. Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology 2011; 76:2002-9.
34. Wehner MR, Chren MM, Nameth D, Choudhry A, Gaskins M, Nead KT, et al. International prevalence of indoor tanning: a systematic review and meta-analysis. JAMA Dermatol 2014; 150:390-400.
35. Lazovich D, Vogel RI, Berwick M, Weinstock MA, Anderson KE, Warshaw EM. Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 2010;19: 1557-68.
36. Cust AE, Armstrong BK, Goumas C, Jenkins MA, Schmid H, Hopper JL, et al. Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 2011;128:2425-35.
37. Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 2012;345:e4757.
38. Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin 2010; 60:301-16.
39. Maley A, Rhodes AR. Cutaneous melanoma: preoperative tumor diameter in a general dermatology outpatient setting. Dermatol Surg 2014;40:446-54.
40. Scope A, Dusza SW, Halpern AC, Rabinovitz H, Braun RP, Zalaudek I, et al. The ''ugly duckling'' sign: agreement between observers. Arch Dermatol 2008;144:58-64.
41. Wazaefi Y, Gaudy-Marqueste C, Avril MF, Malvehy J, Pellacani G, Thomas L, et al. Evidence of a limited intra-individual diversity of nevi: intuitive perception of dominant clusters is a crucial step in the analysis of nevi by dermatologists. J Invest Dermatol 2013;133:2355-61.
42. McWhirter JE, Hoffman-Goetz L. Visual images for patient skin self-examination and melanoma detection: a systematic review of published studies. J Am Acad Dermatol 2013;69: 47-55.
43. Grob JJ, Gaudy C. Early detection of melanoma. Discussing a new approach [in French]. Rev Prat 2007;57:1397-400.
44. Richtig E, Santigli E, Fink-Puches R, Weger W, Hofmann-Wellenhof R. Assessing melanoma risk factors: how closely do patients and doctors agree? Public Health 2008;122: 1433-9.
45. Robinson JK, Stapleton J, Turrisi R. Relationship and partner moderator variables increase self-efficacy of performing skin self-examination. J Am Acad Dermatol 2008;58:755-62.
46. Martin RA, Weinstock MA, Risica PM, Smith K, Rakowski W. Factors associated with thorough skin self-examination for the early detection of melanoma. J Eur Acad Dermatol Venereol 2007;21:1074-81.
47. Carriere P, Baade P, Newman B, Aitken J, Janda M. Cancer screening in Queensland men. Med J Aust 2007;186:404-7.
48. Robinson JK, Turrisi R, Stapleton J. Efficacy of a partner assistance intervention designed to increase skin self-examination performance. Arch Dermatol 2007;143: 37-41.
49. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol 2008;144:515-21.
50. Fears TR, Guerry D 4th, Pfeiffer RM, Sagebiel RW, Elder DE, Halpern A, et al. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 2006;24:3590-6.
51. Mar V, Wolfe R, Kelly JW. Predicting melanoma risk for the Australian population. Australas J Dermatol 2011;52:109-16.
52. Fortes C, Mastroeni S, Bakos L, Antonelli G, Alessandroni L, Pilla MA, et al. Identifying individuals at high risk of melanoma: a simple tool. Eur J Cancer Prev 2010;19:393-400.
53. Williams LH, Shors AR, Barlow WE, Solomon C, White E. Identifying persons at highest risk of melanoma using self-assessed risk factors. J Clin Exp Dermatol Res 2011;2: 1000129.
54. Guther S, Ramrath K, Dyall-Smith D, Landthaler M, Stolz W. Development of a targeted risk-group model for skin cancer screening based on more than 100 000 total skin examinations. J Eur Acad Dermatol Venereol 2012;26:86-94.
55. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002;3:159-65.
56. Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001;137:1343-50.
57. Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008;159: 669-76.
58. Carli P, de Giorgi V, Chiarugi A, Nardini P, Weinstock MA, Crocetti E, et al. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. J Am Acad Dermatol 2004;50:683-9.
59. Zalaudek I, Kittler H, Marghoob AA, Balato A, Blum A, Dalle S, et al. Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study. Arch Dermatol 2008;144:509-13.
60. Herschorn A. Dermoscopy for melanoma detection in family practice. Can Fam Physician 2012;58:740-5, e372-8.
61. Menzies SW, Emery J, Staples M, Davies S, McAvoy B, Fletcher J, et al. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol 2009;161:1270-7.
62. Abbas Q, Celebi ME, Fondón Garca I, Rashid M. Lesion border detection in dermoscopy images using dynamic programming. Skin Res Technol 2011;17:91-100.
63. Bourne P, Rosendahl C, Keir J, Cameron A. BLINCK-A diagnostic algorithm for skin cancer diagnosis combining clinical features with dermatoscopy findings. Dermatol Pract Concept 2012;2:202a212.
64. Gereli MC, Onsun N, Atilganoglu U, Demirkesen C. Comparison of two dermoscopic techniques in the diagnosis of clinically atypical pigmented skin lesions and melanoma: seven-point and three-point checklists. Int J Dermatol 2010; 49:33-8.
65. Goodson AG, Florell SR, Hyde M, Bowen GM, Grossman D. Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg 2010;36:1087-98.
66. Rademaker M, Oakley A. Digital monitoring by whole body photography and sequential digital dermoscopy detects thinner melanomas. J Prim Health Care 2010;2: 268-72.
67. Salerni G, Carrera C, Lovatto L, Mart-Laborda RM, Isern G, Palou J, et al. Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma. J Am Acad Dermatol 2012;67:836-45.
68. Hofmann-Wellenhof R, Wurm EM, Ahlgrimm-Siess V, Richtig E, Koller S, Smolle J, et al. Reflectance confocal microscopy-state-of-art and research overview. Semin Cutan Med Surg 2009;28:172-9.
69. Guitera P, Menzies SW, Longo C, Cesinaro AM, Scolyer RA, Pellacani G. In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal cases. J Invest Dermatol 2012;132:2386-94.
70. Guitera P, Moloney FJ, Menzies SW, Stretch JR, Quinn MJ, Hong A, et al. Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy. JAMA Dermatol 2013;149:692-8.
71. Haniffa MA, Lloyd JJ, Lawrence CM. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic. Br J Dermatol 2007;156:1350-2.
72. Monheit G, Cognetta AB, Ferris L, Rabinovitz H, Gross K, Martini M, et al. The performance of MelaFind: a prospective multicenter study. Arch Dermatol 2011;147:188-94.
73. Wells R, Gutkowicz-Krusin D, Veledar E, Toledano A, Chen SC. Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Arch Dermatol 2012;148:1083-4.
74. Aberg P, Birgersson U, Elsner P, Mohr P, Ollmar S. Electrical impedance spectroscopy and the diagnostic accuracy for malignant melanoma. Exp Dermatol 2011; 20:648-52.
75. Mohr P, Birgersson U, Berking C, Henderson C, Trefzer U, Kemeny L, et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Res Technol 2013;19:75-83.
76. Ferris LK, Harris RJ. New diagnostic aids for melanoma. Dermatol Clin 2012;30:535-45.
77. Wolf JA, Moreau JF, Akilov O, Patton T, English JC 3rd, Ho J, et al. Diagnostic inaccuracy of smartphone applications for melanoma detection. JAMA Dermatol 2013;149: 422-6.